BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12963438)

  • 21. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
    Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
    Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L3T4+ T cells induce hepatic lesions resembling primary biliary cirrhosis in mice with graft-versus-host reactions due to major histocompatibility complex class II disparity.
    Saitoh T; Fujiwara M; Asakura H
    Clin Immunol Immunopathol; 1991 Jun; 59(3):449-61. PubMed ID: 2029796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of CD4+ and CD8+ lymphocyte subsets by streptozotocin in the popliteal lymph node assay. II. Comparison with acute graft-vs-host reaction in H-2 incompatible F1 mouse hybrids.
    Krzystyniak K; Panaye G; Descotes J; Revillard JP
    Immunopharmacol Immunotoxicol; 1992; 14(4):865-82. PubMed ID: 1363474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of IL-6-signaling inhibits the pathogenesis of CD4+ T cell-mediated lethal graft-versus-host reaction against minor histocompatibility antigen.
    Noguchi D; Wakita D; Ohkuri T; Tajima M; Chamoto K; Kitamura H; Nishimura T
    Immunol Lett; 2011 May; 136(2):146-55. PubMed ID: 21256159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphokine synthesis in vivo in an acute murine graft-versus-host reaction: mRNA and protein measurements in vivo and in vitro reveal marked differences between actual and potential lymphokine production levels.
    Troutt AB; Kelso A
    Int Immunol; 1993 Apr; 5(4):399-407. PubMed ID: 8494826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological characteristics of lupus nephritis in F1 mice with chronic graft-versus-host reaction across MHC class II difference.
    Ito S; Ueno M; Nishi S; Arakawa M; Ikarashi Y; Saitoh T; Fujiwara M
    Autoimmunity; 1992; 12(2):79-87. PubMed ID: 1617113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. Role of cytotoxic T lymphocytes directed against receptors for the major histocompatibility complex.
    Kosmatopoulos K; Scott-Algara D; Orbach-Arbouys S; Halle-Pannenko O
    Transplantation; 1988 Oct; 46(4):570-4. PubMed ID: 3262942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular basis of the local graft-versus-host reaction in rat kidney.
    Bolton EM; Gracie JA; O'Reilly LA; Bradley JA
    Immunology; 1988 Oct; 65(2):285-91. PubMed ID: 3263945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study on graft-versus-host reaction (GVHR) by Simonsen's splenomegaly assay. Cells and antigen systems involved in induction of GVHR.
    OnoƩ K; Iwabuchi K; Katsume C; Gotohda T; Arase A; Hatakeyama S; Mishima M; Good RA; Ogasawara K
    Acta Pathol Jpn; 1989 Feb; 39(2):101-10. PubMed ID: 2785742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft-versus-host reaction and GvH disease.
    Harada T
    Tohoku J Exp Med; 1994 May; 173(1):171-81. PubMed ID: 7809907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production.
    Tomura M; Nakatani I; Murachi M; Tai XG; Toyo-oka K; Fujiwara H
    Transplantation; 1997 Sep; 64(5):757-63. PubMed ID: 9311716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Graft-versus-host reaction-induced immune modulation. I. Donor-recipient genetic disparity and the differential expression of Lyt-2, L3T4, and Ly-6 during acute reactions in the host thymus.
    Levy RB; Cotterell AH; Jones M; Malek TR
    J Immunol; 1988 Mar; 140(6):1717-25. PubMed ID: 3257983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerulopathy induced by graft-versus-host reaction in the rat. Requirement of donor CD4+ T lymphocytes and MHC class II incompatibility at the lymphoid compartment.
    Aten J; Stet RJ; Wagenaar-Hilbers JP; Weening JJ; Fleuren GJ; Nieuwenhuis P
    Scand J Immunol; 1992 Jan; 35(1):93-105. PubMed ID: 1346473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory T cells and liver pathology in a murine graft versus host response model.
    Miyazaki T; Doy M; Unno R; Honda A; Ikegami T; Itoh S; Bouscarel B; Matsuzaki Y
    Hepatol Res; 2009 Jun; 39(6):585-94. PubMed ID: 19260998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ability of murine cytomegalovirus and class I major histocompatibility complex-disparate parental cells to induce alterations characteristic of severe graft-versus-host reactions.
    Cray C; Levy RB
    Transplantation; 1989 Dec; 48(6):1057-63. PubMed ID: 2556816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A
    J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific and nonspecific resistance to local graft-versus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. I. Two distinct mechanisms.
    Kosmatopoulos K; Scott-Algara D; Cabannes J; Orbach-Arbouys S
    Transplantation; 1987 Aug; 44(2):267-73. PubMed ID: 2888224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
    Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
    Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.